Takaomi Sanda

Sanda Takaomi

  • Assistant Professor, Department of Medicine
  • Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Academic Qualifications
  • PhD, Nagoya City University Graduate School of Medical Sciences, Japan
  • MD, Nagoya City University Medical School, Japan
Research Interest(s)
  • T Cell Leukaemia
  • Hematopoiesi
  • Transcription Factors
  • Tyrosine Kinases
  • Zebrafish
  • Lymphoma
  • Others
Recent Publications
  • 1. Wong, R. W. J., Ishida, T., & Sanda, T. (2018). Targeting general transcriptional machinery as a therapeutic strategy for adult T-cell leukemia. Molecules, 23(5). doi:10.3390/molecules23051057
  • 2. Leong, W. Z., Tan, S. H., Phuong, C. T. N., Amanda, S., Yam, A. W. Y., Liau, W. -S., . . . Sanda, T. (2017). ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. GENES & DEVELOPMENT, 31(23-24), 2343-2360. doi:10.1101/gad.302646.117
  • 3. Wong, R. W. J., Phuong, C. T. N., Leong, W. Z., Yam, A. W. Y., Zhang, T., Asamitsu, K., . . . Sanda, T. (2017). Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. BLOOD, 130(21), 2326-2338. doi:10.1182/blood-2017-06792184
  • 4. Sanda, T. (2017). RUNX1 in T-ALL: tumor suppressive or oncogenic?. BLOOD, 130(15), 1686-1688. doi:10.1182/blood-2017-08-802181
  • 5. Tan, S. H., Bertulfo, F. C., & Sanda, T. (2017). Leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Frontiers in Oncology, 7(SEP). doi:10.3389/fonc.2017.00218